Clinical and hemodynamic performance of the freestyle aortic root bioprosthesis

Annals of Thoracic Surgery

Volumn 67, Issue 2, 1999, Pages 345-349

  Cartier, Paul C ^a   Dumesnil, Jean G ^a   Métras, Jacques ^a   Desaulniers, Denis ^a   Doyle, Daniel P ^a   Lemieux, Michel D ^a   Raymond, Gilles ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; AORTA PROSTHESIS; AORTA ROOT; AORTA VALVE DISEASE; ARTICLE; BLEEDING; CLINICAL TRIAL; ENDOCARDITIS; FEMALE; FOLLOW UP; HEMODYNAMICS; HEMOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGICAL COMPLICATION; PERFORMANCE; PRESSURE GRADIENT; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THROMBOEMBOLISM;

EID: 0032918171     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)01350-2     Document Type: Article

References (14)

1. Dumesnil J.G., Yogonathan A.P. Valve prosthesis hemodynamic and the problem of high transprosthetic pressure gradients. Eur J Cardiothorac Surg. 6:(Suppl 1):1992;S34-S38.
2. O'Brien M.F., McGiffin D.C., Stafford E.G. Allograft aortic valve implantation technique for all types of aortic valve and root pathology . Ann Thorac Surg. 48:1989;600-609.
3. Edmunds L.H., Clark R.E., Cohn L.H., Grunkemeier G.L., Miller D.C., Weisel R.D. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg. 62:1996;932-935.
4. Dumesnil J.G., Honos G.N., Lemieux M., Beauchemin J. Validation and applications of indexed aortic prosthetic valve areas calculated by Doppler echocardiography. J Am Coll Cardiol. 16:1990;637-643.
5. Dumesnil J.G., LeBlanc M.H., Cartier P.C., et al. Distinctive hemodynamic features of the Freestyle aortic bioprosthesis as compared to stented bioprosthesis. [Abstract] J Am Coll Cardiol. 29:(Suppl A):1997;466A.
6. Aupart M., Neville P., Meurisse Y., Dreyfus X., Sirinelli A., Marchand M. The Carpentier-Edwards pericardial mitral valve intermediate results in 121 patients . Gabbay S., Frater R.W.M. New horizons and the future of heart valve bioprostheses. 1994;123-134 Silent Partners, Inc, Austin, Texas.
7. Franzen S.F., Huljebrant I.E., Konstantinov I.E., Nylander E., Olin C.L. Aortic valve replacement for aortic stenosis in patients with small aortic root. J Heart Valve Dis. 5:(Suppl 3):1996;284-288.
8. Kitamura M., Satoh M., Hachida M., Endo M., Hashimoto A., Koyanagi H. Aortic valve replacement in small aortic annulus with or without annular enlargement. J Heart Valve Dis. 5:(Suppl 3):1996;289-293.
9. Stephen A.M. Cerebral injury and cardiac operations. Ann Thorac Surg. 56:(Suppl 5):1993;S86-S91.
10. Nussmeier N.A., Arlund C., Slogoff S. Neuropsychiatric complications after cardiopulmonary bypass cerebral protection by a barbiturate . Anesthesiology. 64:1986;165-170.
11. David T.E., Feindel C.M., Bos R., Dale L., Sun Z. Mid-term results of aortic valve replacement with a stentless porcine aortic valve. Gabbay S., Frater R.W.M. New horizons and the future of heart valve bioprostheses. 1994;171-182 Silent Partners, Inc, Austin, Texas.
12. Kirklin K.J., Smith D., Novick W., et al. Long-term function of cryopreserved aortic homografts. J Thorac Cardiovasc Surg. 106:1993;154-166.
13. Del Rizzo D.F., Goldman B.S., Christakis G.T., David T.E. Hemodynamic benefits of the Toronto stentless valve. J Thorac Cardiovasc Surg. 112:1996;1431-1446.
14. Girardot M.N., Girardot J.M., Schoen F.J. Alpha-amino oleic acid, a new compound, prevents calcification of bioprosthesis heart valves. [Abstract] Trans Soc Biomater. 14:1991;114.